The upregulated genes were enriched in TNF-α signaling via NF-kB, hypoxia, androgen response, and mTORC1 signaling, indicating that C7 displayed strongly tumor-promoting progression under treating with enzalutamide (Figure 1I). The gene discussed is TNF; the disease is neoplasm.